A Supplies Solution

Bitesize Bio contributor Megan Cartwright this week proposes a system to keep lab supply orders and fulfillments straight. "Ordering, receiving, auditing, and following-up on outstanding orders are all boring and time-consuming aspects of a lab manager's job," Cartwright says. But, "given the money involved and research's time-sensitive nature, these mundane but important tasks must be as simple as possible for all lab members," she adds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.